E
Outset Medical, Inc. OM
$0.553 -$0.0005-0.09%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 8/15/2024Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 8/15/2024 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 2.13 to 2.9.
D
Sell 7/18/2024Upgraded
Outset Medical, Inc. (OM) was upgraded to D- from E+ on 7/18/2024 due to an increase in the growth index, volatility index and valuation index. EBIT increased 1.18% from -$37.35M to -$36.91M.
E
Sell 10/12/2023Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 10/12/2023 due to a decline in the total return index and volatility index.
D
Sell 9/27/2023Upgraded
Outset Medical, Inc. (OM) was upgraded to D- from E+ on 9/27/2023 due to an increase in the valuation index and growth index. Operating cash flow increased 37.05% from -$44.76M to -$28.18M, total revenue increased 7.69% from $33.47M to $36.04M, and earnings per share increased from -$0.9014 to -$0.9.
E
Sell 5/11/2023Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 5/11/2023 due to a decline in the volatility index, total return index and growth index.
D
Sell 3/14/2023Downgrade
Outset Medical, Inc. (OM) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell 2/14/2023Upgraded
Outset Medical, Inc. (OM) was upgraded to D from D- on 2/14/2023 due to an increase in the total return index.
D
Sell 2/8/2023Downgrade
Outset Medical, Inc. (OM) was downgraded to D- from D on 2/8/2023 due to a large decline in the solvency index and valuation index. Debt to equity increased from 0.1 to 0.11, and the quick ratio declined from 5.19 to 5.04.
D
Sell 5/16/2022Upgraded
Outset Medical, Inc. (OM) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index and volatility index.
E
Sell 5/13/2022Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell 5/4/2022Upgraded
Outset Medical, Inc. (OM) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index, volatility index and total return index.
E
Sell 5/1/2022Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell 4/21/2022Upgraded
Outset Medical, Inc. (OM) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index and valuation index.
E
Sell 4/20/2022Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index, total return index and growth index. EBIT declined 35.37% from -$30.14M to -$40.8M, earnings per share declined from -$0.654 to -$0.8741, and operating cash flow declined 16.16% from -$28.13M to -$32.68M.
D
Sell 11/23/2021Upgraded
Outset Medical, Inc. (OM) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and valuation index.
D
Sell 11/8/2021Downgrade
Outset Medical, Inc. (OM) was downgraded to D- from D on 11/8/2021 due to a major decline in the efficiency index and valuation index. Total capital declined 4.61% from $469.45M to $447.8M, and net income declined 0.87% from -$30.21M to -$30.47M.
D
Sell 12/8/2020None
Outset Medical, Inc. (OM) was downgraded to D from U on 12/08/2020.
Weiss Ratings